IPAS966
Desistência total de designação em razão de renúncia à Inscrição Internacional que afeta o Brasil
Protocolo: 2020056601 (09/10/2025) Petição (tipo): Protocolo de Madri - DEATH
RPI 2872
21/01/2026
Voltar para busca
Dado oficial do INPI
BREKVUE
Essa marca aparece no histórico oficial do INPI.
Mesmo quando o status está encerrado, o histórico ajuda a calibrar o risco, evitar repetição de erros e definir uma estratégia segura de naming.
Designação definitivamente arquivadaTipo: VerbalEscritório: Brasil
Andamento no INPI
- Depósito02/07/25
- Publicação11/11/25
- Arquivado
- Deferimento
- Concessão
- Vigente
Pedido arquivado pelo INPI. O processo foi encerrado sem chegar a registro.
Verificar se este nome está livreÚltima movimentação publicada pelo INPI: 21/01/2026. Atualizamos a cada nova RPI, publicada semanalmente.
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação INPI
Designação definitivamente arquivada
Tipo de processo
Pedido de registro
Eventos registrados
2
Atualização mais recente
21/01/2026
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
02/07/2025
Data de registro
-
Data de expiração
09/10/2025
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Natureza
Madri
Produto/Serviço
Escritório responsável
Brasil
Tipo de titular
NÃO RESIDENTE
Localização do titular
GB
Titulares e representantes
Titulares
Glaxo Group Limited
Representantes
Sem dados de representantes.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for use as anti-infectivespharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegaloviruspharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptomspharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressantspharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorderspharmaceutical preparations for the treatment of atherosclerosispharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight managementpharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorderspharmaceutical preparations for the prevention and treatment of oncological diseases and disorderspharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitispharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatiguepharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the bloodpharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritispharmaceutical preparations for use in ophthalmologypharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseasespharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone disorders, androgen disorders and estrogen disorderspharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid related disorders, namely acidifiers to increase levels of gastric acid to decrease stomach pH for human purposespharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorderpharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorderspharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertilitypharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparationspharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorderspharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids, Leiomyoma, pre-eclampsia and pre-term labourpharmaceutical preparations for use in urologypharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal diseasepharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndromepharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosispharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness)pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychosespharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acnepharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuriespharmaceutical preparations for the treatment of malariapharmaceutical preparations for the treatment of tuberculosisallergy medicationsvaccines for human use
Publicações
Histórico de despachos e eventos da marca no INPI.
2 publicações encontradas
IPAS756
Publicação de pedido de registro para oposição (exame formal de designação concluído)
RPI 2862
11/11/2025
Glaxo Group Limited também protege tecnologia e design no INPI
548 pedidos de patente e 44 desenhos industriais no mesmo titular.
Patentes
TRATAMENTO PARA VITILIGOMÉTODOS PARA PRODUÇÃO DE UMA PROTEÍNA RECOMBINANTE EM UMA CÉL...COMPOSIÇÃO DENTÍFRICACOMPOSIÇÃO DE DENTIFRÍCIO, USO DE UMA HIDROXIAPATITA SINTERIZ...MÉTODO PARA PRODUZIR UMA PROTEÍNA RECOMBINANTE, MÉTODO PARA C...FORMULAÇÃO FARMACÊUTICA, DISPOSITIVO ADAPTADO PARA DISTRIBUIÇ...
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BREKVUE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o INPI por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.